Skip to main content

Construction of cDNA Libraries in Vaccinia Virus

  • Protocol
Vaccinia Virus and Poxvirology

Part of the book series: Methods in Molecular Biology ((MIMB,volume 269))

Abstract

Poxvirus expression vectors have gained widespread use for expression of foreign proteins and as delivery vehicles for vaccine antigens. We have developed a novel method using the poxvirus as a library vector for functional selection of specific cDNA. Poxviruses have several unique and useful properties as a library vector. Most importantly, because poxviruses are packaged into fully infectious particles in the cell cytoplasm, specific recombinants can be readily recovered even from a very small number of selected cells. Moreover, in contrast to libraries constructed in retrovirus or plasmid-based vectors, recombinant vaccinia virus can be efficiently recovered even from cells that have been induced to undergo apoptosis or cessation of cell growth. In the past, the major obstacle in this application to poxviruses has been the low frequency with which recombinants can be generated. The most commonly used method to construct recombinant poxvirus is homologous recombination. The frequency of recombinants derived in this manner is of the order of 0.1%, sufficient to recover a recombinant of a purified DNA clone in a transfer plasmid, but far too low to permit construction of a representative cDNA library. We have developed a method that generates nearly 100% recombinant vaccinia viruses at good titer. We have termed this method trimolecular recombination. cDNA libraries of as many as 107 or more independent viral recombinants can be constructed by trimolecular recombination. For the first time, large, diverse, and representative cDNA libraries can be screened in a vaccinia virus-based expression vector.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Moss, B. (1991) Vaccinia virus: A tool for research and vaccine development. Science 252, 1662–1667.

    Article  PubMed  CAS  Google Scholar 

  2. Merchlinsky, M., Eckert, D., Smith, E., and Zauderer, M. (1997) Construction and characterization of vaccinia direct ligation vectors. Virology 238, 444–451.

    Article  PubMed  CAS  Google Scholar 

  3. Somogyi, P., Frazier, J., and Skinner, M. (1993) Fowlpox virus host range restriction: Gene expression, DNA replication, and morphogenesis in nonpermissive mammalian cells. Virology 197, 439–444

    Article  PubMed  CAS  Google Scholar 

  4. Scheiflingler, F., Dorner, F., and Falkner, F. (1992) Construction of chimeric vaccinia virus by molecular cloning and packaging. Proc. Natl. Acad. Sci. USA 89, 9977–9981.

    Article  Google Scholar 

  5. Smith, E. S., Mandokhot, A., Evans, E. E., et al. (2001) Lethality-based selection of recombinant genes in mammalian cells: Application to identifying tumor antigens. Nature Med. 7, 967–972.

    Article  PubMed  CAS  Google Scholar 

  6. Earl, P. L. and Moss, B. (1991) Generation of recombinant vaccinia viruses, in Current Protocols in Molecular Biology (Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K., eds.), Greene/Whiley-Interscience, New York, pp. 16.17.1–16.17.16.

    Google Scholar 

  7. In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells. US Patent application no. 20020123057, September 5, 2002 (international patent application no. WO 02102855, December 27, 2002).

    Google Scholar 

  8. Method of producing or identifying intrabodies in eukaryotic cells. US patent application no. 10/052,942, January 23, 2002 (international patent application WO 02086096, October 31, 2002).

    Google Scholar 

  9. T cells specific for target antigens and vaccines based thereon. US patent application no.08/935,377, September 22, 1997 (international patent application no. WO 0028016, May 18, 2000).

    Google Scholar 

  10. Methods of producing a library and methods of selecting polynucleotides of interest. US patent application no. 20030022157, January 30, 2003 (international patent application no. WO 0172995, October 4, 2001).

    Google Scholar 

  11. Methods of identifying regulator molecules. US patent application no. 20020192675, December 19, 2002 (international patent application no. WO 02062822, August 15, 2002).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Smith, E.S., Shi, S., Zauderer, M. (2004). Construction of cDNA Libraries in Vaccinia Virus. In: Isaacs, S.N. (eds) Vaccinia Virus and Poxvirology. Methods in Molecular Biology, vol 269. Humana Press. https://doi.org/10.1385/1-59259-789-0:065

Download citation

  • DOI: https://doi.org/10.1385/1-59259-789-0:065

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-229-2

  • Online ISBN: 978-1-59259-789-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics